BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 36328488)

  • 1. A Pilot Study of
    Duan H; Ghanouni P; Daniel B; Rosenberg J; Davidzon GA; Aparici CM; Kunder C; Sonn GA; Iagaru A
    J Nucl Med; 2023 Apr; 64(4):592-597. PubMed ID: 36328488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Pilot Study of
    Duan H; Ghanouni P; Daniel B; Rosenberg J; Thong A; Kunder C; Aparici CM; Davidzon GA; Moradi F; Sonn GA; Iagaru A
    J Nucl Med; 2023 May; 64(5):744-750. PubMed ID: 36396456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation of
    Duan H; Baratto L; Fan RE; Soerensen SJC; Liang T; Chung BI; Thong AEC; Gill H; Kunder C; Stoyanova T; Rusu M; Loening AM; Ghanouni P; Davidzon GA; Moradi F; Sonn GA; Iagaru A
    J Nucl Med; 2022 Dec; 63(12):1829-1835. PubMed ID: 35552245
    [No Abstract]   [Full Text] [Related]  

  • 4. PSMA- and GRPR-Targeted PET: Results from 50 Patients with Biochemically Recurrent Prostate Cancer.
    Baratto L; Song H; Duan H; Hatami N; Bagshaw HP; Buyyounouski M; Hancock S; Shah S; Srinivas S; Swift P; Moradi F; Davidzon G; Iagaru A
    J Nucl Med; 2021 Nov; 62(11):1545-1549. PubMed ID: 33674398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of
    Schollhammer R; Robert G; Asselineau J; Yacoub M; Vimont D; Balamoutoff N; Bladou F; Bénard A; Hindié E; Gallerande HC; Morgat C
    J Nucl Med; 2023 Mar; 64(3):379-385. PubMed ID: 36215569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective Study of the Radiolabeled GRPR Antagonist BAY86-7548 for Positron Emission Tomography/Computed Tomography Imaging of Newly Diagnosed Prostate Cancer.
    Touijer KA; Michaud L; Alvarez HAV; Gopalan A; Kossatz S; Gonen M; Beattie B; Sandler I; Lyaschenko S; Eastham JA; Scardino PT; Hricak H; Weber WA
    Eur Urol Oncol; 2019 Mar; 2(2):166-173. PubMed ID: 31017093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective Evaluation of
    Minamimoto R; Sonni I; Hancock S; Vasanawala S; Loening A; Gambhir SS; Iagaru A
    J Nucl Med; 2018 May; 59(5):803-808. PubMed ID: 29084827
    [No Abstract]   [Full Text] [Related]  

  • 9. Value of
    Beheshti M; Taimen P; Kemppainen J; Jambor I; Müller A; Loidl W; Kähkönen E; Käkelä M; Berndt M; Stephens AW; Minn H; Langsteger W
    Eur Radiol; 2023 Jan; 33(1):472-482. PubMed ID: 35864350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced Acquisition Time per Bed Position for PET/MRI Using
    Duan H; Baratto L; Hatami N; Liang T; Levin CS; Khalighi MM; Iagaru A
    AJR Am J Roentgenol; 2022 Feb; 218(2):333-340. PubMed ID: 34406051
    [No Abstract]   [Full Text] [Related]  

  • 11. Pilot Comparison of ⁶⁸Ga-RM2 PET and ⁶⁸Ga-PSMA-11 PET in Patients with Biochemically Recurrent Prostate Cancer.
    Minamimoto R; Hancock S; Schneider B; Chin FT; Jamali M; Loening A; Vasanawala S; Gambhir SS; Iagaru A
    J Nucl Med; 2016 Apr; 57(4):557-62. PubMed ID: 26659347
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Burger IA; Müller J; Donati OF; Ferraro DA; Messerli M; Kranzbühler B; Ter Voert EEGW; Muehlematter UJ; Rupp NJ; Mortezavi A; Eberli D
    J Nucl Med; 2019 Aug; 60(8):1118-1123. PubMed ID: 30683764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of 3 Interpretation Criteria for
    Toriihara A; Nobashi T; Baratto L; Duan H; Moradi F; Park S; Hatami N; Aparici CM; Davidzon G; Iagaru A
    J Nucl Med; 2020 Apr; 61(4):533-539. PubMed ID: 31562226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic accuracy of fully hybrid [
    Ghezzo S; Mapelli P; Samanes Gajate AM; Palmisano A; Cucchiara V; Brembilla G; Bezzi C; Suardi N; Scifo P; Briganti A; De Cobelli F; Chiti A; Esposito A; Picchio M
    Eur J Nucl Med Mol Imaging; 2024 Feb; 51(3):907-918. PubMed ID: 37897615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pilot study of the diagnostic utility of
    Vlachostergios PJ; Niaz MJ; Thomas C; Christos PJ; Osborne JR; Margolis DJA; Khani F; Bander NH; Scherr DS; Tagawa ST
    Prostate; 2022 Mar; 82(4):483-492. PubMed ID: 34985786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The PRIMARY Score: Using Intraprostatic
    Emmett L; Papa N; Buteau J; Ho B; Liu V; Roberts M; Thompson J; Moon D; Sheehan-Dare G; Alghazo O; Agrawal S; Murphy D; Stricker P; Hope TA; Hofman MS
    J Nucl Med; 2022 Nov; 63(11):1644-1650. PubMed ID: 35301240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Association of Tissue Change and Treatment Success During High-intensity Focused Ultrasound Focal Therapy for Prostate Cancer.
    Khandwala YS; Soerensen SJC; Morisetty S; Ghanouni P; Fan RE; Vesal S; Rusu M; Sonn GA
    Eur Urol Focus; 2023 Jul; 9(4):584-591. PubMed ID: 36372735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PET Imaging Using Gallium-68 (
    Duan H; Iagaru A
    PET Clin; 2022 Oct; 17(4):621-629. PubMed ID: 36153233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosis of recurrent prostate cancer with PET/CT imaging using the gastrin-releasing peptide receptor antagonist
    Wieser G; Popp I; Christian Rischke H; Drendel V; Grosu AL; Bartholomä M; Weber WA; Mansi R; Wetterauer U; Schultze-Seemann W; Meyer PT; Jilg CA
    Eur J Nucl Med Mol Imaging; 2017 Aug; 44(9):1463-1472. PubMed ID: 28417160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined Utility of
    Kalapara AA; Ballok ZE; Ramdave S; O'Sullivan R; Ryan A; Konety B; Grummet JP; Frydenberg M
    Eur Urol Oncol; 2022 Jun; 5(3):314-320. PubMed ID: 33741337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.